Skip to Main Content

Paper Details

Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus.
Clin Gastroenterol Hepatol
35
2022
Human, Human Immunodeficiency Virus, NAFLD, NASH, NASH cirrhosis, Nonalcoholic Fatty Liver Disease, Nonalcoholic fatty liver disease, PWH, Persons, cardiovascular disease, chronic liver disease, diabetes mellitus, end-stage liver disease, fibrosis, human, human immunodeficiency virus, nonalcoholic steatohepatitis, persons, steatosis
Author NameAffiliation
Susanna NaggieDuke University School of Medicine
Mark S SulkowskiJohns Hopkins School of Medicine
Rohit LoombaUniversity of California San Diego School of Medicine
Raymond T ChungMassachusetts General Hospital, Harvard Medical School
  • 1 - 4

Datasets

Release 1.2